Stop Selling the Dream, Start Telling the Truth
Part of our Enterprise Leadership Series, exploring how leaders drive impact beyond their function.
"People don't resent setbacks. They resent discovering that the story they believed in was incomplete."
Biopharma is inherently risky. Everyone says they know this. But optimism is contagious, and leaders lean into the breakthrough narrative. The problem isn't risk—it's when risk goes unnamed until it's unavoidable. That's when trust shatters.
I recently explored this in BioSpace, where I write regularly about the realities of leadership in biopharma. The piece unpacks why transparency isn't a red flag—it's a filter. The best leaders don't pretend the path is clear. They show the terrain and invite people to join anyway. And the employees who ask sharper questions aren't difficult—they're signaling they're ready to own the exchange.
Here's the full article, originally published in BioSpace: 👉 Stop Selling the Dream, Start Telling the Truth
Key Takeaways:
Why transparency attracts the right people—and keeps them committed
How to name risks and rewards side by side without creating fear
What Shackleton got right about expectation-setting
The questions employees should ask—and answer for themselves
Reflection Questions for Readers:
Are you telling the whole story—or just the version you wish were true?
When things get hard, do your people feel informed or blindsided?
What questions should you be asking about your current role?
More from the Enterprise Leadership series:
